Vol.22 No.1

Original Article

Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity

Authors

Kuninobu Wakabayashi¹ , Kumiko Otsuka¹ , Michihito Sato¹ , Ryo Takahashi¹ , Tsuyoshi Odai¹ , Takeo Isozaki¹ , Nobuyuki Yajima¹ , Yusuke Miwa¹ , Tsuyoshi Kasama¹

Received:

20 January 2011

Accepted:

27 April 2011

Published online:

24 May 2011

Full Text

PDF　(member's only)

Abstract

Macrophage migration inhibitory factor (MIF) is recognized to be an important mediator in several inflammatory disorders, including rheumatoid arthritis (RA) and vasculitis. To evaluate the role of MIF in rheumatoid vasculitis (RV), we determined serum levels of MIF by enzyme-linked immunosorbent assay in RA patients with and without vasculitis and assessed their relationship to disease activity. Serum was obtained from 95 RA patients during active disease states [49 without vasculitis, 35 with extra-articular manifestations without histologically proven vasculitis, and 11 with histologically proven vasculitis] and from 22 healthy individuals. Vasculitis disease activity was assessed using the Birmingham Vasculitis Activity Score (BVAS). MIF levels were significantly higher in RA patients than in controls. Moreover, MIF levels were significantly higher in RA patients with vasculitis than in those without vasculitic complications. In all RA patients, a statistically significant positive correlation was observed between serum MIF levels and each of the following: serum levels of C-reactive protein, rheumatoid factor, and thrombomodulin; and the erythrocyte sedimentation rate. In the RV group, the elevation of MIF levels correlated with the BVAS. Our findings suggest that MIF may serve as an additional serologic inflammatory marker of disease activity in RV, and it may be implicated in the pathogenesis of RV.

Key words

Cytokine - Macrophage migration inhibitory factor (MIF) - Rheumatoid arthritis - Rheumatoid vasculitis